[{"Assets_0_FY_USD":34986000000.0,"EarningsPerShareDiluted_4_FY_USD":3.01,"EarningsPerShareDiluted_1_FY_USD":0.71,"EarningsPerShareBasic_4_FY_USD":3.01,"EarningsPerShareBasic_1_FY_USD":0.71,"StockholdersEquityConverted_0_FY_USD":14127000000.0,"StockholdersEquity_0_FY_USD":14031000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1633000000.0,"RevenuesConverted_1_FY_USD":5973000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1637000000.0,"NetIncomeLossConverted_1_FY_USD":1160000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":5940000000.0,"CommonStockSharesConverted_0_FY_shares":2200000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":1.61,"CommonStockDividendsPerShareDeclared_1_FY_USD":0.41,"NetIncomeLossConverted_4_FY_USD":4947000000.0,"RevenuesConverted_4_FY_USD":22561000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20190225"}]